CIK 0001000694
- Large accelerated filer
NOVAVAX INC
Sign in to watch- Ticker
- NVAX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222816046
- Phone
- +1 240-268-2000
- Business address
- 21 FIRSTFIELD RD, GAITHERSBURG, MD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-18 | EVANS GARY C Director | Exercise or conversion | +4,000 | $27.60 | $110K | 328,479 |
| 2020-08-18 | EVANS GARY C Director | Exercise or conversion | +4,000 | $27.60 | $110K | 332,479 |
| 2020-08-18 | EVANS GARY C Director | Sale | −10,500 | $150.44 | $1.6M | 321,979 |
| 2020-08-18 | EVANS GARY C Director | Exercise or conversion · Stock Option (Right to Buy) | −1,000 | 0 | ||
| 2020-08-18 | EVANS GARY C Director | Exercise or conversion · Stock Option (Right to Buy) | −1,500 | 0 | ||
| 2020-08-18 | EVANS GARY C Director | Exercise or conversion · Stock Option (Right to Buy) | −4,000 | 0 | ||
| 2020-08-18 | EVANS GARY C Director | Exercise or conversion · Stock Option (Right to Buy) | −4,000 | 0 | ||
| 2020-06-25 | Trizzino John EVP, CBO and CFO | Grant or award · Restricted Stock Units | +2,500 | 2,500 | ||
| 2020-06-25 | Herrmann John A III EVP, Chief Legal Officer | Grant or award · Restricted Stock Units | +2,500 | 2,500 | ||
| 2020-06-25 | Glenn Gregory M President, R&D | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2020-06-25 | Erck Stanley C President and CEO | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2020-06-25 | Trizzino John EVP, CBO and CFO | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2020-06-25 | Herrmann John A III EVP, Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +99,000 | 99,000 | ||
| 2020-06-25 | MOTT DAVID M Director | Grant or award · Stock Option (Right to buy) | +4,400 | 4,400 | ||
| 2020-06-25 | MCMANUS MICHAEL A JR Director | Grant or award · Stock Option (Right to buy) | +6,900 | 6,900 | ||
| 2020-06-25 | MCMANUS MICHAEL A JR Director | Grant or award · Restricted Stock Units | +3,450 | 3,450 | ||
| 2020-06-25 | King Rachel K. Director | Grant or award · Stock Option (Right to buy) | +6,900 | 6,900 | ||
| 2020-06-25 | King Rachel K. Director | Grant or award · Restricted Stock Units | +3,450 | 3,450 | ||
| 2020-06-25 | EVANS GARY C Director | Grant or award · Stock Option (Right to buy) | +6,900 | 6,900 | ||
| 2020-06-25 | EVANS GARY C Director | Grant or award · Restricted Stock Units | +3,450 | 3,450 |
Page 85 of 87 · 1,734 trades